Active ingredientZalcitabineCat. No. P-Z002-001CAS 7481-89-2Family · Pharmaceutical analytical standards
Zalcitabine
A nucleoside analogue antiretroviral derived from cytidine (ddC), developed against HIV at the US National Cancer Institute: in 1992 it became the third antiretroviral approved by the FDA, and it was withdrawn from the market at the end of 2006. This family brings together the active ingredient.
Did you know?Chemist Jerome Horwitz first synthesised it in the 1960s; in 1964 he had also made zidovudine (AZT), then intended as an anticancer drug.
Go to the active ingredient →Active ingredientZalcitabineCat. No. P-Z002-001CAS 7481-89-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.